Strategies to decrease inequalities in cancer therapeutics, care and prevention
Ringborg U, von Braun J, Celis J, Baumann M, Berns A, Eggermont A, Heard E, Heitor M, Chandy M, Chen C, Costa A, De Lorenzo F, De Robertis E, Dubee F, Ernberg I, Gabriel M, Helland Å, Henrique R, Jönsson B, Kallioniemi O, Korbel J, Krause M, Lowy D, Michielin O, Nagy P, Oberst S, Paglia V, Parker M, Ryan K, Sawyers C, Schüz J, Silkaitis K, Solary E, Thomas D, Turkson P, Weiderpass E, Yang H. Strategies to decrease inequalities in cancer therapeutics, care and prevention. Molecular Oncology 2024, 18: 245-279. PMID: 38135904, PMCID: PMC10850793, DOI: 10.1002/1878-0261.13575.Peer-Reviewed Original ResearchConceptsComprehensive cancer centreEuropean Academy of Cancer SciencesEurope's Beating Cancer PlanHealthcare systemCancer research continuumPrevention modalitiesCost-effective healthcareCancer research infrastructureCancer PlanCancer incidencePatient needsPatient careResearch continuumPrevention opportunitiesPrevention programsCancer preventionCancer centreOutcomes researchHealthcareEconomic statusPontifical Academy of SciencesDecreasing inequalityState-of-the-art patient careCancer scienceResearch portfolioPrevalence and predictors of aspirin/NSAID use among patients with Lynch syndrome (LS).
Singhal S, Chertok Y, Osorio N, Chavez J, Riggs E, Daly M, Hall M. Prevalence and predictors of aspirin/NSAID use among patients with Lynch syndrome (LS). Journal Of Clinical Oncology 2024, 42: 19-19. DOI: 10.1200/jco.2024.42.3_suppl.19.Peer-Reviewed Original ResearchLynch syndromeAssociated with CPCP useLS patientsPatient advocacy websitesPatient-level factorsPersonal historyColonoscopy surveillanceCP benefitColorectal CAHereditary cancerPatients' perceptionsLifetime riskAdvocacy websitesMarital statusCP usersImpact uptakePrevention benefitsLS participantsPerceptions of CPE-surveyCancer CenterPrevention modalitiesNon-usersPerceived inconvenience
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply